Local treatment of HPV‐induced skin lesions by Cidofovir

Human papillomavirus (HPV) induced epithelial cell proliferation is responsible for a broad range of lesions. Treatment of such lesions is characterized by a high relapse rate. Four patients are described who were treated locally with cidofovir (cream 1% or injection of 2.5 mg/ml solution) for multi‐treated relapsing HPV‐associated lesions. Three of the four patients had a complete response. The fourth patient showed a clinical response in the first cycle of treatment, but new lesions appeared during four successive cycles of cidofovir. J. Med. Virol. 67:241–245, 2002. © 2002 Wiley‐Liss, Inc.

[1]  M. Wulfsohn,et al.  Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  P. Delvenne,et al.  Inhibiting effects of cidofovir (HPMPC) on the growth of the human cervical carcinoma (SiHa) xenografts in athymic nude mice. , 1998, Oncology research.

[3]  P. Delvenne,et al.  Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. , 1998, Oncology research.

[4]  A. Ferenczy,et al.  Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. , 1998, Archives of dermatology.

[5]  J. Cherrington,et al.  Clinical uses of cidofovir , 1997, Reviews in medical virology.

[6]  K. Cundy,et al.  Bioavailability and metabolism of cidofovir following topical administration to rabbits. , 1997, Antiviral research.

[7]  J. L. Smith,et al.  Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase. , 1996, Biochemical pharmacology.

[8]  E. Clercq.  Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections , 1996 .

[9]  K. Stone,et al.  Human papillomavirus infection and genital warts: update on epidemiology and treatment. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Connelly,et al.  Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates. , 1995, Molecular pharmacology.

[11]  T. Wright,et al.  Comparison of CO2 laser surgery and loop electrosurgical excision/fulguration procedure (LEEP) for the treatment of vulvar intraepithelial neoplasia (VIN) , 1993, International Journal of Gynecologic Cancer.

[12]  M. Ling.  THERAPY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTIONS. PART II: METHODS OF TREATMENT , 1992, International journal of dermatology.

[13]  Kling Ar.  Genital warts--therapy. , 1992 .

[14]  E. Clercq.  Broad-spectrum anti-DNA virus and anti-retrovirus activity of phosphonylmethoxyalkylpurines and -pyrimidines , 1991 .

[15]  P. Hogan.  Recurrent condylomata acuminata treated with recombinant interferon alfa-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group. , 1991, JAMA.

[16]  E. De Clercq,et al.  Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG). , 1990, Virology.

[17]  Krebs Hb.  Treatment of extensive vulvar condylomata acuminata with topical 5-fluorouracil. , 1990 .

[18]  J. Douglas,et al.  A randomized trial of combination therapy with intralesional interferon alpha 2b and podophyllin versus podophyllin alone for the therapy of anogenital warts. , 1990, The Journal of infectious diseases.

[19]  Pride Gl.  Treatment of large lower genital tract condylomata acuminata with topical 5-fluorouracil. , 1990 .

[20]  H. Homesley,et al.  Intralesional interferon alfa-2b for the treatment of genital warts. , 1990, American journal of obstetrics and gynecology.

[21]  E. De Clercq,et al.  Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines. , 1987, Antiviral research.

[22]  M. Gellan,et al.  Cryotherapy compared with trichloroacetic acid in treating genital warts. , 1987, Genitourinary medicine.

[23]  J. Balzarini,et al.  A novel selective broad-spectrum anti-DNA virus agent , 1986, Nature.

[24]  E. McBurney,et al.  Carbon dioxide laser treatment of verrucae vulgares. , 1984, The Journal of dermatologic surgery and oncology.